Emmanuelle Charpentier: h-index, Total Citations, and Citation Map
Emmanuelle Charpentier's h-index is 66 (130 i10-index, 70,207+ total citations across 269+ publications) according to Google Scholar as of August 2026. Emmanuelle Charpentier is affiliated with Scientific and Managing Director, Max Planck Unit for the Science of Pathogens.
Emmanuelle Charpentier is a researcher affiliated with Scientific and Managing Director, Max Planck Unit for the Science of Pathogens, specializing in Microbiology, CRISPR-Cas, Regulatory RNAs. Their work has been cited 70,207 times. This profile visualizes their global influence, spanning a global audience.
Emmanuelle Charpentier's Citation Metrics
Bibliometric impact based on 269 indexed publications.
- H-Index
- 66
- i10-Index
- 130
- Total Citations
- 70,207
- Citing Countries
- 0
As of August 2026.
Emmanuelle Charpentier has an h-index of 66 and 70,207 total citations across 269 publications, with research cited by institutions in 0 countries.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity
201223,743
Top Citing Countries
Top Citing Institutions
No institution data available.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Emmanuelle Charpentier's research
Emmanuelle Charpentier is a researcher in Microbiology, CRISPR-Cas and Regulatory RNAs at Scientific and Managing Director, Max Planck Unit for the Science of Pathogens. Their work has been cited 70,207 times across 269 publications (h-index 66), according to Google Scholar.
Their most-cited work, “A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity” (2012), has accumulated 23,743 citations. Other influential works include “A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity” (2012) with 23,743 citations and “The new frontier of genome engineering with CRISPR-Cas9” (2014) with 9,792 citations.
